GVB Biopharma, a developer, manufacturer, and global distributor of hemp-derived cannabinoid products, announced the launch of its new CBT Isolate.
CBT, also known as Cannabicitran, is a rare cannabinoid that, like other rare cannabinoids, demonstrates distinct properties and potential benefits for users seeking new functional product formulations. It's for use in tinctures, topicals, edibles, and more.
Key Benefits and Features of GVB Biopharma's CBT Isolate
- High Purity: Produced under stringent quality controls using state-of-the-art extraction and refinement processes.
- Reliable Consistency: GVB Biopharma's certified manufacturing ensures uniform quality and potency with every batch.
- Versatile Applications: Suitable for a wide range of product formats, including oils, beverages, supplements, and topicals.
- Exceptional Quality Assurance: Backed by rigorous testing, transparent COAs, and expert support.
With the addition of CBT Isolate to its diverse portfolio, GVB Biopharma continues to reinforce its position as a trusted partner for businesses seeking high-quality, innovative hemp-derived solutions. The launch reflects GVB Biopharma's dedication to empowering brands with the tools and expertise necessary to create differentiated consumer experiences within the dynamic cannabis and wellness sectors.
